HomeOwner SearchCategory Search
Visit USCOJournal of Pharmaceutical and Biomedical Analysis [Published: 2019-05-20. Issue: vol. 171, 15 July 2019]
Serial Registration
Copyright Title
Journal of Pharmaceutical and Biomedical Analysis [Published: 2019-05-20. Issue: vol. 171, 15 July 2019]
Status
Published
on 6 Sept 2019
Year of Creation
2019
Copyright Claimant
Elsevier
Registration Number
TX0008791570
on 6 Sept 2019Copyright Summary
The U.S. Copyright record (Registration Number: TX0008791570) dated 6 Sept 2019, pertains to an electronic file (eService) titled "Journal of Pharmaceutical and Biomedical Analysis [Published: 2019-05-20. Issue: vol. 171, 15 July 2019]" created in 2019. The copyright holder is Elsevier, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Elsevier.
Application Details
Registration Number
TX0008791570
Registration Date
9/6/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Elsevier
First Publication Nation
Netherlands
ISSN
0731-7085
Preexisting Material
Permissioned materials
Notes
Rights Note: permissions@elsevier.com
Copyright Local Holdings: vol. 171, 15 July 2019 Created 2019 Pub. 2019-05-20 Reg. 2019-09-27 TX0008791570 AARM
Material Matter Claimed Note: compilation, editing, text, Figures
Statements
Application Title Statement: Journal of Pharmaceutical and Biomedical Analysis
Author Statement: Elsevier employer for hire Domicile: Netherlands Citizenship: Netherlands Authorship: Collective Work Authorship
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.